Update information
November 2010: Recommendation 1.5 was updated and replaced by NICE technology appraisal guidance on imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (NICE technology appraisal guidance 209).
ISBN: 978-1-4731-7002-5